Located on the island nation of Mauritus, in the Indian Ocean, R&D laboratory Biolabex has announced the launch of its development and manufacturing activities in BioPark Mauritius. This is the first GMP-compliant CDMO (Contract Development and Manufacturing Organization) in the Indian Ocean.
The 500 square meters of laboratory space is fully equipped to provide cosmetics, pharmaceutical and nutraceutical companies with R&D and consulting services in early development, formulation, manufacturing, concept marketing, regulatory affairs and compliance audits.
Marc Labiche, CEO of Biolabex, said, “Mauritius is widely regarded as one of the world’s biodiversity hotspots and we saw great potential in locating our first laboratory here. We also have an office in Paris, and this dual presence allows BIOLABEX and its clients to draw benefits from the best of both worlds—close proximity to a rich source of active ingredients, and to leading players in the pharmaceutical and cosmetics industries. These factors place BIOLABEX in a prime position to serve as a global hub.”
Labiche added, “For now, our focus is on the cosmetics, pharmaceutical and nutraceutical market in Europe and the U.S., before looking toward promising markets such as Africa and Asia. Our future plans include expansion of our clientele to other industries, such as medical devices, food supplements and agriculture.”